Use of continuous glucose monitoring (CGM) within 12 months of type 1 diabetes diagnosis ameliorates ethnic disparity in glycaemic control in children, according to an analysis of data from the KIWIDIAB network. Data were collected for 206 children aged <15 years diagnosed between 1 October 2020 and 1 October 2021. CGM use was 56.7% for Māori and 77.2% for European children. At 12 months post-diagnosis, glycosylated haemoglobin (HbA1c) was 10.8 mmol/mol (95% CI 2.3-19.4 mmol/mol; p = 0.013) higher in Māori vs European children without CGM, but was similar between ethnic groups in those using CGM.
